{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:01:17Z","timestamp":1770973277746,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12938-015-0009-5","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T03:42:40Z","timestamp":1425354160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery"],"prefix":"10.1186","volume":"14","author":[{"given":"Yue","family":"Ruan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hood","family":"Thabit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata E","family":"Wilinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2011.32","volume":"7","author":"R Hovorka","year":"2011","unstructured":"Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol. 2011;7:385\u201395.","journal-title":"Nat Rev Endocrinol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2337\/dc12-0816","volume":"36","author":"D Elleri","year":"2013","unstructured":"Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care. 2013;36:838\u201344.","journal-title":"Diabetes Care"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"d1855","DOI":"10.1136\/bmj.d1855","volume":"342","author":"R Hovorka","year":"2011","unstructured":"Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011;342:d1855.","journal-title":"BMJ"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2337\/dc11-1430","volume":"34","author":"HR Murphy","year":"2011","unstructured":"Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34:2527\u20139.","journal-title":"Diabetes Care"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S2213-8587(14)70114-7","volume":"2","author":"H Thabit","year":"2014","unstructured":"Thabit H, Lubina-Solomon A, Stadler M, Leelarathna L, Walkinshaw E, Pernet A, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol. 2014;2:701\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJMoa1314474","volume":"371","author":"SJ Russell","year":"2014","unstructured":"Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371:313\u201325.","journal-title":"N Engl J Med"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2337\/dc13-1030","volume":"37","author":"K Kumareswaran","year":"2014","unstructured":"Kumareswaran K, Thabit H, Leelarathna L, Caldwell K, Elleri D, Allen JM, et al. Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study. Diabetes Care. 2014;37:1198\u2013203.","journal-title":"Diabetes Care"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/193229680900300106","volume":"3","author":"BP Kovatchev","year":"2009","unstructured":"Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3:44\u201355.","journal-title":"J Diabetes Sci Technol"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/193229681000400117","volume":"4","author":"ME Wilinska","year":"2010","unstructured":"Wilinska ME, Chassin LJ, Acerini CL, Allen JM, Dunger DB, Hovorka R. Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diabetes Sci Technol. 2010;4:132\u201344.","journal-title":"J Diabetes Sci Technol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/dom.12228","volume":"16","author":"H Thabit","year":"2014","unstructured":"Thabit H, Hovorka R. Glucose control in non-critically ill inpatients with diabetes: towards closed-loop. Diabetes Obes Metab. 2014;16:500\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"9_CR11","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","volume":"51","author":"A Mari","year":"2002","unstructured":"Mari A, Tura A, Gastaldelli A, Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes. 2002;51 Suppl 1:S221\u20136.","journal-title":"Diabetes"},{"key":"9_CR12","first-page":"744","volume":"83","author":"R Hovorka","year":"1998","unstructured":"Hovorka R, Chassin L, Luzio SD, Playle R, Owens DR. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:744\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cmpb.2014.07.004","volume":"117","author":"Y Ruan","year":"2014","unstructured":"Ruan Y, Thabit H, Kumareswaran K, Hovorka R. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery. Comput Methods Programs Biomed. 2014;117:298\u2013307.","journal-title":"Comput Methods Programs Biomed"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1008929526011","volume":"10","author":"DJ Lunn","year":"2000","unstructured":"Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325\u201337.","journal-title":"Stat Comput"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","volume":"64","author":"DJ Spiegelhalter","year":"2002","unstructured":"Spiegelhalter DJ, Best NG, Carlin BR, van der Linde A. Bayesian measures of model complexity and fit. J Roy Stat Soc B. 2002;64:583\u2013616.","journal-title":"J Roy Stat Soc B"},{"key":"9_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9780470434567","volume-title":"Bayesian modeling using WinBUGS","author":"I Ntzoufras","year":"2009","unstructured":"Ntzoufras I. Bayesian modeling using WinBUGS. Hoboken, N.J.: Wiley; 2009."},{"key":"9_CR17","volume-title":"SPSS: statistical package for the social sciences","author":"NH Nie","year":"1975","unstructured":"Nie NH. SPSS: statistical package for the social sciences. 2dth ed. New York: McGraw-Hill; 1975.","edition":"2d"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/db11-1701","volume":"61","author":"HJ Woerle","year":"2012","unstructured":"Woerle HJ, Carneiro L, Derani A, Goke B, Schirra J. The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes. Diabetes. 2012;61:2349\u201358.","journal-title":"Diabetes"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1530\/JOE-13-0381","volume":"220","author":"MH Kim","year":"2014","unstructured":"Kim MH, Jee JH, Park S, Lee MS, Kim KW, Lee MK. Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. J Endocrinol. 2014;220:117\u201328.","journal-title":"J Endocrinol"},{"issue":"4","key":"9_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11892-014-0473-5","volume":"14","author":"PM Thule","year":"2014","unstructured":"Thule PM, Umpierrez G. Sulfonylureas: a new look at old therapy. Curr Diabetes Rep. 2014;14(4):473.","journal-title":"Curr Diabetes Rep"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1210\/jc.2010-2178","volume":"96","author":"I Vardarli","year":"2011","unstructured":"Vardarli I, Nauck MA, Kothe LD, Deacon CF, Holst JJ, Schweizer A, et al. Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as \u201cisoglycemic\u201d intravenous glucose without numerically changing the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab. 2011;96:945\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1172\/JCI112308","volume":"77","author":"KS Polonsky","year":"1986","unstructured":"Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, et al. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest. 1986;77:98\u2013105.","journal-title":"J Clin Invest"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2337\/diabetes.50.1.150","volume":"50","author":"E Breda","year":"2001","unstructured":"Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes. 2001;50:150\u20138.","journal-title":"Diabetes"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1210\/jc.2013-4519","volume":"99","author":"H Thabit","year":"2014","unstructured":"Thabit H, Kumareswaran K, Haidar A, Leelarathna L, Caldwell K, Elleri D, et al. Glucose turnover after replacement of usual therapy by insulin in insulin-naive type 2 diabetes subjects. J Clin Endocrinol Metab. 2014;99:2225\u201332.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.2337\/dc13-0485","volume":"36","author":"A Haidar","year":"2013","unstructured":"Haidar A, Elleri D, Kumareswaran K, Leelarathna L, Allen JM, Caldwell K, et al. Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes. Diabetes Care. 2013;36:e173\u20134.","journal-title":"Diabetes Care"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-015-0009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12938-015-0009-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-015-0009-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-015-0009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:50:47Z","timestamp":1630572647000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-015-0009-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1186\/s12938-015-0009-5","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]},"assertion":[{"value":"15 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}